An ASNC Information Statement: Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis
Resource Type
Information Statements, Practice Points
Year Published
2022
Related Resources
Cases
PET Case: A Case of Pacemaker Lead Infection in Patient with S. Lugdunensis Bacteremia
Case summary: 64-year-old female with history of CRT-D implantation admitted with acute…
ASNC Comments to CMS on 2026 Medicare Physician Fee Schedule Proposed Rule
ASNC_Comments-to-CMS-on_CY2026-MPFS-Proposed-Rule_1832_09-12-2025_FINAL
ASNC Comments to CMS on 2026 HOPPS Proposed Rule
ASNC-Comments-to-CMS-on-CY2026-HOPPS-Proposed Rule_09_11_2025_Final
